Different biochemical profile of stable and decompensated systolic heart failure patients due to ischemic or dilated cardiomyopathy hospitalized in the tertiary cardiology center (RCD code: III-1)
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2014, Vol 1, Issue 7
Abstract
Aim: This study aims to compare the extended biochemical profile of unselected and consecutive systolic heart failure (SHF) patients admitted electively and urgently to the tertiary cardiology center. Methods: This study is a retrospective analysis of the 310 consecutive SHF patients who were hospitalized between January 2011 till December 2013. Data about health status of the patients, medications, as well as laboratory data, including indicators of myocardial damage, such as high–sensitivity troponins (hs-Tn), MB isoform of creatin kinase (CK-MB), marker of myocardial strain (NT-proBNP) and inflammatory parameters [high-sensitivity C-reactive protein (hs-CRP) and white blood cell count (WBC)] were gathered from medical histories and documentations. Results: Out of 310 patients more than a half (n=172, 55%) were admitted electively. Urgent patients had higher heart rate, NYHA class, and lower left ventricular ejection fraction (EF). Elective ischemic cardiomyopathy (ICM) patients were more likely to be older male with higher EF, and increased level of hs-TnT and CK-MB. As for urgent admissions, the frequency of male sex was similar in both groups but ICM patients were significantly older, had worse kidney function, and increased level of hs-TnT and NT-proBNP than patients with dilated cardiomyopathy (DCM). Conclusions: Systolic HF patients admitted electively and urgently differ significantly. Moreover, patients with different HF etiologies, such as ischemic and dilated cardiomyopathy, admitted either electively or urgently have different profiles. The observed elevation of ischemic and inflammatory parameters in decompensated HF may indicate possible mechanisms of HF worsening, leading to the acute admissions. The true meaning of the observations as well as potential additional anti-inflammatory and/or anti-ischemic treatment in stable HF to prevent acute episodes could a subject for further studies. JRCD 2014; 1 (7): 7–12
Authors and Affiliations
Pawel Rubis, Jakub Stępniewski, Mariusz Staszek, Łukasz Sikora, Patrycja Faltyn, Ewa Zawadzka, Lusine Khachatryan, Piotr Podolec
Keywords
Related Articles
- EP ID EP245422
- DOI 10.20418/jrcd.vol1no7.127
- Views 99
- Downloads 0
“One of the greatest disease is to be nobody to anybody”
Saint Mother Teresa of CalcuttaDear Readers,Before we go any further, try to ponder the quote once said by the Saint Teresa of Calcutta. She was by far one of the most entitled person in the world to say such an unpleasa...
Journal of Rare Cardiovascular Diseases: “Conquering new territories” – a new educational program on rare diseases for medical acolytes
Dear Readers,Nowadays, we witness dramatic changes in the perception of rare diseases. Thanks to the European Union(EU) regulations but more importantly due to increasing pressure from the spontaneous patients’ organiza...
Update on Cardiac Tumors – review (RCD code: VI)
The prevalence of cardiac tumors is 0.021% (1 person in 5000). These data are based on a meta-analysis of pathological studies from the early decades of the twentieth century. It is likely that nowadays the incidence of...
Evaluation of arterial stiffness in patients with coronary atherosclerosis, cardiac syndrome X and systemic lupus erythematosus (RCD code: I-3C.1)
Objectives: Arterial stiffness manifested by high pulse wave velocity (PWV) consists a risk factor of atherosclerosis and cardio-vascular complications. Systemic lupus erythematosus (SLE) is a generalized autoimmune dise...
Ebstein Anomaly
Ebstein anomaly (EA) is a rare congenital malformation of the heart that is characterized by apical displacement of the septal and posterior tricuspid valve leaflets, with atrialization of the right ventricle and variabl...